Elsevier

Genomics

Volume 77, Issues 1–2, September 2001, Pages 105-113
Genomics

Regular Article
Linkage Disequilibrium at the Angelman Syndrome Gene UBE3A in Autism Families

https://doi.org/10.1006/geno.2001.6617Get rights and content

Abstract

Autistic disorder is a neurodevelopmental disorder with a complex genetic etiology. Observations of maternal duplications affecting chromosome 15q11–q13 in patients with autism and evidence for linkage and linkage disequilibrium to markers in this region in chromosomally normal autism families indicate the existence of a susceptibility locus. We have screened the families of the Collaborative Linkage Study of Autism for several markers spanning a candidate region covering ∼2 Mb and including the Angelman syndrome gene (UBE3A) and a cluster of γ-aminobutyric acid (GABAA) receptor subunit genes (GABRB3, GABRA5, and GABRG3). We found significant evidence for linkage disequilibrium at marker D15S122, located at the 5′ end of UBE3A. This is the first report, to our knowledge, of linkage disequilibrium at UBE3A in autism families. Characterization of null alleles detected at D15S822 in the course of genetic studies of this region showed a small (∼5-kb) genomic deletion, which was present at somewhat higher frequencies in autism families than in controls.

References (48)

  • E.R. Martin et al.

    Tests for linkage and association in nuclear families

    Am. J. Hum. Genet.

    (1997)
  • E.R. Martin et al.

    A test for linkage and association in general pedigrees: the pedigree disequilibrium test

    Am. J. Hum. Genet.

    (2000)
  • A. Bailey et al.

    Autism: the phenotype in relatives

    J. Autism Dev. Disord.

    (1998)
  • E. Fombonne

    The epidemiology of autism: a review

    Psychol. Med.

    (1999)
  • C. Feinstein et al.

    Autism: the point of view from fragile X studies

    J. Autism Dev. Disord.

    (1998)
  • I. Rapin

    Autism

    N. Engl. J. Med.

    (1997)
  • S.L. Smalley

    Autism and tuberous sclerosis

    J. Autism Dev. Disord.

    (1998)
  • A. Pickles

    Latent-class analysis of recurrence risks for complex phenotypes with selection and measurement error: a twin and family history study of autism

    Am. J. Hum. Genet.

    (1995)
  • A. Bailey

    Autism as a strongly genetic disorder: evidence from a British twin study

    Psychol. Med.

    (1995)
  • M. Rutter et al.

    Genetics and child psychiatry: II Empirical research findings

    J. Child. Psychol. Psychiatry

    (1999)
  • Ledbetter, D. H., and Ballabio, A.1995. Molecular cytogenetics of contiguous gene syndromes: mechanisms and...
  • U. Albrecht

    Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons

    Nat. Genet.

    (1997)
  • C. Rougeulle et al.

    The Angelman syndrome candidate gene, UBE3A/E6-AP, is imprinted in brain

    Nat. Genet.

    (1997)
  • Cited by (130)

    • Genetic variation of UBE3A is associated with schizotypy in a population of typical individuals

      2019, Psychiatry Research
      Citation Excerpt :

      A later study by the same group, using six intronic SNP markers within UBE3A did not find any significant pattern of preferential transmission in autism families (Nurmi et al., 2003). Guffanti et al. (2011) found that an allele of the microsatellite marker D15S122 showed preferential under transmission to affected children, partially replicating the earlier results of Nurmi et al. (2001). Here, the microsatellite marker was analyzed as four classes of different alleles designated as 222-bp, 224-bp, 226-bp and other lengths, with the three main alleles covering the majority of the variation.

    • Network Analysis of UBE3A/E6AP-Associated Proteins Provides Connections to Several Distinct Cellular Processes

      2018, Journal of Molecular Biology
      Citation Excerpt :

      In addition, UBE3A is linked to two different neurological disorders. Increased gene dosage of UBE3A is implicated in some forms of autism spectrum disorders (ASDs) [8–10], and the loss of function of UBE3A in the central nervous system is the cause of Angelman syndrome (AS), a neurodevelopmental disorder characterized by severe mental retardation, ataxia, loss of speech, seizures, and other abnormalities [11–14]. Approximately 10% of patients that meet the clinical criteria for AS have no identified UBE3A molecular defect [15], suggesting that in addition to molecular mechanisms directly affecting UBE3A, perturbations in other genes that share a pathway or work through convergent pathways with UBE3A may also cause AS.

    View all citing articles on Scopus
    *

    To whom correspondence and reprint requests should be addressed. Fax: (615) 936-3626. E-mail: [email protected].

    View full text